Bill > HR124

This bill, named the "Byron Nash Renal Medullary Carcinoma Awareness Act of 2023", seeks to amend Title XIX of the Social Security Act to provide incentives for educating Medicaid recipients with sickle cell disease about the risk of renal medullary carcinoma (RMC). Specifically, the bill modifies Section 1903(a)(3)(E)(ii) of the Social Security Act by inserting the term "renal medullary carcinoma" alongside existing language about health risks. Renal medullary carcinoma is a rare and aggressive form of kidney cancer that disproportionately affects individuals with sickle cell disease, a genetic blood disorder more common among African Americans. The amendment will require Medicaid programs to include education about RMC when discussing health risks with sickle cell patients. The changes will take effect for medical services provided on or after the date of the bill's enactment, potentially helping to increase awareness and early detection of this serious health condition among a vulnerable patient population.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/124/all-info